Procept (PRCT): 50% rise on high volume. Why? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Procept (PRCT): 50% rise on high volume. Why?

PRCT 30.75

-1.8%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Gerald Thomas who wrote (114)	4/17/1997 6:43:00 PM
From: Douglas	of 455

The results of the long-awaited N-9 study of women in Cameroon was released on April 3, 1997. A two-year study to determine whether vaginal contraceptive film containing spermicide used with condoms prevents the transmission of sexually transmitted diseases (STDs) has concluded that the spermicidal film is safe to use but does not confer any additional protection to women from HIV, gonorrhea or chlamydia infection beyond the protection provided by condoms. Unfortunately, the news is not good for women... This is good news for Procept! The entire Family Health International (FHI) article is available at: fhi.org FHI's homepage is: fhi.org The Institute of Tropical Medicine, Antwerp is at: itg.be

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next